Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI for Radiotherapy Treatment Planning of Stage III NSCLC: an MRI Optimization Study in Healthy Volunteers and Patients

NCT02076282 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT02076282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02076282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI for Radiotherapy Treatment Planning of Stage III NSCLC: an MRI Optimization Study in Healthy Volunteers and Patients
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2014
Completion date
November 30, 2015
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii non-small cell lung cancer